The stock of Jaguar Health Inc (NASDAQ:JAGX) last traded at $3.91, up 3.44% from the previous session.
JAGX stock price is now -58.47% away from the 50-day moving average and -66.03% away from the 200-day moving average. The market capitalization of the company currently stands at $18.73M.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $5, Cantor Fitzgerald recently initiated with Overweight rating for Jaguar Health Inc (NASDAQ: JAGX). On July 11, 2017, Rodman & Renshaw recently initiated its ‘Buy’ rating on the stock quoting a target price of $2
A total of 12.63% of the company’s stock is owned by insiders.
During the past 12 months, Jaguar Health Inc has had a low of $3.07 and a high of $43.19. As of last week, the company has a debt-to-equity ratio of 2.31, a current ratio of 1.89, and a quick ratio of 1.39. The fifty day moving average price for JAGX is $9.3973 and a two-hundred day moving average price translates $11.416525 for the stock.
The latest earnings results from Jaguar Health Inc (NASDAQ: JAGX) was released for 2024-03-31. According to the Biotechnology Company, earnings per share came in at -540, missing analysts’ expectations of -337.5 by -202.5. This compares to -$146.15 EPS in the same period last year. The net profit margin was -377.95% and return on equity was -351.06% for JAGX. The company reported revenue of $2.35 million for the quarter, compared to $1.97 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 19.22 percent. For the current quarter, analysts expect JAGX to generate $4.01M in revenue.
